On June 6, 2017, Microspherix LLC filed a complaint for patent infringement against Merck & Co., Inc., Merck Sharp & Dohme Corp., N.V. Organon, and Merck Sharp & Dohme B.V. on June 5 in the United States District Court for the District of New Jersey. The lawsuit involves an implantable progestin contraceptive developed by Merck that allegedly infringes Microspherix’s implantable brachytherapy strand. The patents at issue are U.S. Patent Nos. 6,514,193; 8,821,835; 9,636,401; and 9,636,402.
By: Neha Bhat